CoChat

Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol

Open access

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Context: Up to 3% of US and UK populations are prescribed glucocorticoids (GC). Suppression of the hypothalamo–pituitary–adrenal axis with the potential risk of adrenal crisis is a recognized complication of therapy. The 250 μg short Synacthen stimulation test (SST) is the most commonly used dynamic assessment to diagnose adrenal insufficiency. There are challenges to the use of the SST in routine clinical practice, including both the staff and time constraints and a significant recent increase in Synacthen cost. Methods: We performed a retrospective analysis to determine the prevalence of adrenal suppression due to prescribed GCs and the utility of a morning serum cortisol for rapid assessment of adrenal reserve in the routine clinical setting. Results: In total, 2773 patients underwent 3603 SSTs in a large secondary/tertiary centre between 2008 and 2013 and 17.9% ( n =496) failed the SST. Of 404 patients taking oral, topical, intranasal or inhaled GC therapy for non-endocrine conditions, 33.2% ( n =134) had a subnormal SST response. In patients taking inhaled GCs without additional GC therapy, 20.5% (34/166) failed an SST and suppression of adrenal function increased in a dose-dependent fashion. Using receiver operating characteristic curve analysis in patients currently taking inhaled GCs, a basal cortisol ≥348 nmol/l provided 100% specificity for passing the SST; a cortisol value <34 nmol/l had 100% sensitivity for SST failure. Using these cut-offs, 50% ( n =83) of SSTs performed on patients prescribed inhaled GCs were unnecessary. Conclusion: Adrenal suppression due to GC treatment, particularly inhaled GCs, is common. A basal serum cortisol concentration has utility in helping determine which patients should undergo dynamic assessment of adrenal function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/eje-15-0608

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Excluding patients with underlying pituitary, adrenal or CNS disease, current glucocorticoid therapy is associated with increased rates of SST failure (A). SST failure is common across all routes of glucocorticoid administration, although it is most frequent in patients on oral therapy (B). (*P<0.05, **P<0.01). The impact of inhaled glucocorticoid therapy on the prevalence of adrenal suppression (C, D, E and F). Beclometasone and fluticasone administration cause a dose-dependent increase in SST failure rates (C and D) and absolute reductions in basal and 30-min cortisol levels after synthetic ACTH1 – 24 stimulation (E and F) (basal serum cortisol=black bars, 30-min cortisol=white bars) (*P<0.05 vs lowest daily dose).
Figure 1 Excluding patients with underlying pituitary, adrenal or CNS disease, current glucocorticoid therapy is associated with increased rates of SST failure (A). SST failure is common across all routes of glucocorticoid administration, although it is most frequent in patients on oral therapy (B). (*P<0.05, **P<0.01). The impact of inhaled glucocorticoid therapy on the prevalence of adrenal suppression (C, D, E and F). Beclometasone and fluticasone administration cause a dose-dependent increase in SST failure rates (C and D) and absolute reductions in basal and 30-min cortisol levels after synthetic ACTH1 – 24 stimulation (E and F) (basal serum cortisol=black bars, 30-min cortisol=white bars) (*P<0.05 vs lowest daily dose).CC BY · PubMed Central
Figure 2 Baseline serum cortisol as a predictor of 30-min cortisol levels during an SST. Baseline serum cortisol is graphed against the % likelihood of passing (specificity=continuous line) or failing (sensitivity=dashed line) the SST. (A) Inhaled glucocorticoids. (B) Oral glucocorticoids.
Figure 2 Baseline serum cortisol as a predictor of 30-min cortisol levels during an SST. Baseline serum cortisol is graphed against the % likelihood of passing (specificity=continuous line) or failing (sensitivity=dashed line) the SST. (A) Inhaled glucocorticoids. (B) Oral glucocorticoids.CC BY · PubMed Central
Figure 3 Putative algorithm to aid in the rationalization of assessment of the HPA axis in patients taking inhaled glucocorticoids.
Figure 3 Putative algorithm to aid in the rationalization of assessment of the HPA axis in patients taking inhaled glucocorticoids.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

6 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 154

Metadata

Authors
Woods, C. P., Argese, N., Chapman, M., Boot, C., Webster, R., Dabhi, V., Grossman, A. B., Toogood, A. A., Arlt, W., Stewart, P. M., Crowley, R. K., & Tomlinson, J. W.
Affiliations
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • University of Leeds (GB)
Corresponding author
Tomlinson, Jeremy W
Venue
European Journal of Endocrinology
Published
2015-11
Volume
173
Issue
5
Pages
633-642
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2117978928
Cited by
152
References
48
Citations by year
2026: 9 · 2025: 10 · 2024: 16 · 2023: 14 · 2022: 13 · 2021: 17 · 2020: 23 · 2019: 17 · 2018: 10 · 2017: 10 · 2016: 12 · 2015: 1
FWCI
9.54
Type
journal article
Language
en
Open access
Locations
  • European Journal of Endocrinology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
National Institute for Health and Care Research (NF-SI-0508-10356)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Keywords
adrenal suppression, inhaled corticosteroids, adrenal insufficiency, hypothalamic-pituitary-adrenal axis, adrenal reserve, adrenal crisis, glucocorticoid dose, prevalence, unnecessary testing
MeSH terms
Administration, Inhalation, Adrenal Insufficiency, Adult, Cosyntropin, Glucocorticoids, United Kingdom, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Retrospective Studies, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. https://app.cochat.ai/papers/10.1530/eje-15-0608
The paper
Woods, C. P., Argese, N., Chapman, M., Boot, C., Webster, R., Dabhi, V., Grossman, A. B., Toogood, A. A., Arlt, W., Stewart, P. M., Crowley, R. K., & Tomlinson, J. W. (2015). Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. European Journal of Endocrinology. https://doi.org/10.1530/eje-15-0608

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.